BridgeBio Pharma vs Ionis Pharmaceuticals
BBIO and IONS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BBIO and IONS compare
BridgeBio Pharma is the larger company, worth 2.0 times as much as Ionis Pharmaceuticals ($14.7B against $7.2B).
BridgeBio Pharma grew revenue faster over the last twelve months (167% versus −7.4% for Ionis Pharmaceuticals).
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BBIO | IONS |
|---|---|---|
| Size and price | ||
| Market cap | $14.7B | $7.2B |
| Share price | $74.95 | $43.52 |
| Change, 1 year | 12.5% | −39.5% |
| Change, 5 years | 40.3% | 29.2% |
| Beta (5Y) | 1.13 | 0.71 |
| Employees | 834 | 1,402 |
| StockData Score | ||
| Total score | 3 | 3 |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 15.5× | 8.3× (better) |
| P/B | – | 16.4× |
| FCF yield | −2.5% (better) | −7.8% |
| Fair value | – | $28.12 |
| Margin of safety | – | −54.7% |
| Growth | ||
| Revenue growth (TTM) | 167% (better) | −7.4% |
| Revenue growth, 5Y average | 127% (better) | 5.3% |
| Profitability | ||
| Gross margin | 94.3% | 98.2% (better) |
| Operating margin | −38.5% (better) | −68.0% |
| Net margin | – | −64.7% |
| FCF margin | −39.1% (better) | −64.2% |
| Return on equity | – | −105% |
| Financial health | ||
| Interest coverage | −7.1× (better) | −31.6× |
| Current ratio | 2.09 | 7.89 (better) |
| Altman Z-score | 0.06 | 0.88 (better) |
| Piotroski F-score | – | 4 |
| Dividends and buybacks | ||
| Buyback yield | 1.7% | – |
| Shareholder yield | 1.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 99.1% | 108% |
| Held by insiders | 35.5% | 0.80% |
| Insider net buying, 12 months | −$105M (better) | −$123M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 15.6% | 13.7% |
Go deeper
- BBIO stock overview
- BBIO income statement
- BBIO valuation and score
- IONS stock overview
- IONS income statement
- IONS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.